Staphylococcusaureus(S.aureus)isaubiquitousgram-positivepathogenthatisoneofthe mostfrequentcausesofskinandsofttissueinfections.Frequently,theseinfectionsserveasa preludetoinvasivelife-threateningdiseases.TheprevalenceofsevereS.aureusinfections haveincreasedinhealthypopulations,associatedwiththedevelopmentofbothdrugresistance andhypervirulenceinmethicillin-resistantS.aureus(MRSA)strainssuchUSA300.Thespread ofMRSA-induceddiseaseduringtrainingandmissionassignmentsisawell-documentedthreat tomilitarypublichealth.Awealthofbothclinicalandexperimentalevidencesuggeststhat(1) neutrophils(PMNs)areessentialmediatorsofanti-S.aureushostdefense,and(2)emerging MRSAstrainsreleasetoxinscapableofkillingPMNs,andconsequentlytheycanoverwhelm hostdefenseresponsesandrapidlycausediseaseinimmunecompetentindividuals.The rapidityoftheseeventssuggestsaprotectivevaccinewouldbethebestapproachtodisease control.UsingamodelofhealedMRSAskininfectionthatelicitsprotectiveimmunityagainsta secondMRSAskininfection,weprovideevidencethattheappropriateinductionofhumoraland cellularimmuneresponsescanseparatelybutsynergisticallysupportanti-MRSAeffector responsesandexpeditepathogenclearance.Theresearchplandescribedhereinwilltestthe hypothesesthatactiveimmunizationagainstS.aureusisfeasible,andthatprotectiveantigens includesecretedbacterialvirulencefactors.
The specificaims aredesignedtoevaluatethe pathogenandhost-derivedfactorsthatarerequiredtoinitiateandmaintainant-MRSA protectiveadaptiveimmuneresponses.
In specificaim1 wewillidentifyantigensleadingto protectiveimmunitybysystematicallymeasuringtheprophylacticeffectsofskinchallengewith selectedknockoutstrainsofMRSAfollowedbyrechallengewithWTMRSA.
In aim2, wewill characterizeTfollicularhelperandthegerminalcenterresponsesthatcorrespondwithanti- MRSAprotectiveimmunity,andemployLangerin-DTRmicetodelineatetheskinDC requirementsfortheseprocesses.
In aim3, wewillcharacterizethe cutaneousTcellsignature correspondingwithanti-MRSAprotectiveimmunitybymeasuringthekineticsandtissue distributionpathogenspecificTcellsfollowinginfectionwithstrainsofMRSAthathavebeen engineeredtoexpressovapeptideOVA 323-339.AfterclarifyingtheadaptiveTcellcorrelatesof anti-MRSAprotectiveimmunity,wewillusetheLangerin-DTRsystemtoelucidatethe underlyingDCrequirementsfortheirinduction.Overalltheprogramisdesignedtodissectthe humoralandcellularimmunecomponentsrequiredforaprotectiveimmuneresponsetoMRSA. Onceexplored,thesedatawillprovidethebasistodesignandevaluateapproachestoa preventivevaccine.

Public Health Relevance

Staphylococcusaureus(S.aureus)isoneofthemostfrequentcausesofskinandsofttissue infections.S.aureusinfectionsoftenspreadtointernalsitesandcauseinvasivelife-threatening diseases.TherehasbeenanincreaseinsevereS.aureusinfectionsinhealthyindividuals, associatedwiththespreadofdrugresistantstrainswithheightenedvirulencemechanisms. Becauseoftheirrapiddevelopment,aprotectivevaccinewouldbethemosteffectivewayto preventseriousstaphylococcaldisease.Weproposeinthisapplicationtodefinethe characteristicsofprotectiveimmunitytoS.aureus.Insodoing,wewillprovidetheneeded backgroundfordesignofapreventivevaccine.

Agency
National Institute of Health (NIH)
Institute
Veterans Affairs (VA)
Type
Veterans Administration (IK2)
Project #
1IK2BX004532-01
Application #
9663585
Study Section
Special Emphasis Panel (ZRD1)
Project Start
2020-04-01
Project End
2025-03-31
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
1
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Iowa City VA Medical Center
Department
Type
DUNS #
028084333
City
Iowa City
State
IA
Country
United States
Zip Code
52246